Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEET

v3.20.1
CONSOLIDATED BALANCE SHEET - USD ($)
Feb. 29, 2020
Aug. 31, 2019
Current    
Cash and cash equivalents $ 739,985 $ 1,285,147
Marketable securities (Note 19) 23,623 64,214
Accounts receivable (Note 7) 227,266 273,145
Inventory (Note 8) 124,412 127,396
Prepaid expenses and deposit (Note 18) 64,757 68,927
Total Current Assets 1,180,043 1,818,829
Capital assets, net    
Intellectual property (Note 9) 267,995 265,127
Property & Equipment (Note 10) 538,188 591,263
Total Noncurrent Assets 806,183 856,390
TOTAL ASSETS 1,986,226 2,675,219
Current    
Accounts payable and accrued liabilities (Note 11) 61,690 136,411
Due to a related party (Note 15) 1,600 48,096
Total Current Liabilities 63,290 184,507
TOTAL LIABILITIES 63,290 184,507
STOCKHOLDERS' EQUITY    
Share Capital (Note 12) Authorized: 220,000,000 common voting shares with a par value of $0.Share Capital (Note 12) 001 per share Issued and outstanding: 80,720,879 common shares at February 29, 2020 and 78,787,134 common shares at August 31, 2019 80,721 78,787
Additional paid-in capital (Note 12, 13) 27,524,998 26,172,453
Deficit (25,725,859) (23,868,202)
Equity attributable to shareholders of the Company 1,879,860 2,383,038
Non-Controlling Interest 43,076 107,674
Total Stockholders' Equity 1,922,936 2,490,712
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,986,226 $ 2,675,219